Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease

Abstract

This guideline aims to outline the current evidence for specific indications and to provide clinician aids for consultation and monitoring of hydroxycarbamide. This will enable joint decision-making between clinicians and patients and will improve equity of access to the drug.